Hydroxyethyl Starch (HES) Solutions

Mortality and Renal Injury Requiring Renal Replacement Therapy

• In critically ill adult patients, including patients with sepsis, use of hydroxyethyl starch (HES) products, including 6% hydroxyethyl starch 130/0.4 in 0.9% sodium chloride injection, increases risk of
  • Mortality
  • Renal replacement therapy
• Do not use HES products, including 6% hydroxyethyl starch 130/0.4 in 0.9% sodium chloride injection, in critically ill adult patients, including patients with sepsis.

Patient Counseling Information

• VOLUVEN

Package Inserts

Hydroxyethyl Starch